Roundtable Discussion – Fighting the Next Pandemic with mRNA Technology & Equitable Vaccine Supply Chain for Commercial Markets in Asia
Time: 11:00 am
day: Day Two
Details:
With the Korean Disease Control and Prevention Agency’s mission to invest in the best mRNA technologies to fight the next
pandemic, it’s more important than ever to establish collaborations between Korean and international partners to support
regional and global health through establishment of local manufacturing of vaccine in LMICs
Hear from vaccine experts as they shed light on strategies to overcome the next pandemic through RNA technology innovations.
- How to develop key biopharma partnerships to achieve the impact on global vaccine equity
- How to leverage best practices for mRNA vaccine R&D and local manufacturing
- Outlining current bottlenecks with scaling up to ensure regional capacity and global availability of mRNA vaccines
